TENOFOVIR ALAFENAMIDE EMTRICITABINE BICTEGRAVIR
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TENOFOVIR ALAFENAMIDE EMTRICITABINE BICTEGRAVIR, covering 2020-01-09 to 2020-01-09. Get the full timeline:
Most recent: Clinical Trial Update: Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST [Phase 4]